MicroRNA-645 is an oncogenic regulator in colon cancer

- Guo, S. T., Guo, X. Y., Jin, L., Zhang, X. D., Jiang, C. C., Wang, J., Wang, C. Y., Yang, R. H., Wang, F. H., Li, X. Y., Hondermarck, H., Thorne, R. F., Wang, Y. F.

INPP4B is an oncogenic regulator in human colon cancer

- Guo, S. T., Chi, M. N., Yan, X. G., Farrelly, M., Wang, F. H., Lai, F., Wang, J. F., Li, Y. P., Ackland, S., Scott, R., Agoulnik, I. U., Hondermarck, H., Yang, R. H., Thorne, R. F., Liu, T., Zhang, X. D., Jiang, C. C., Guo, X. Y., Zan, L. K., Wang, C. Y., Xi, Y. F., Jin, L., Croft, A., Tseng, H.-Y.

Regulation of PD-L1: a novel role of pro-survival signalling in cancer

- Chen, J., Jiang, C. C., Jin, L., Zhang, X. D.

Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy

- Chi, M., Chen, J., Ye, Y., Tseng, Hsin-Yi, Lai, F., Tay, K. H., Jin, L., Guo, S. T., Jiang, C. C., Zhang, X. D.

Oncogenic suppression of PHLPP1 in human melanoma

- Dong, L., Jin, L., Guo, S. T., Tseng, H-Y., Wang, C. Y., Wilmott, J. S., Yosufi, B., Yan, X. G., Jiang, C. C., Scolyer, R. A., Zhang, X. D.

Oncogenic suppression of PHLPP1 in human melanoma

- Dong, L., Jin, L., Guo, S. T., Tseng, H-Y., Wang, C. Y., Wilmott, J. S., Yosufi, B., Yan, X. G., Jiang, C. C., Scolyer, R. A., Zhang, X. D.

Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma

- Jiang, C. C., Croft, A., Tseng, H-Y., Guo, S. T., Jin, L., Hersey, P., Zhang, X. D.

AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma

- Hu, W., Jin, L., Jiang, C. C., Long, G. V., Scolyer, R. A., Wu, Q., Zhang, X. D., Mei, Y., Wu, M.

Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3

- Lai, F., Guo, S. T., Norman, J., Liu, T., Hersey, P., Zhang, X. D., Jin, L., Jiang, C. C., Wang, C. Y., Croft, A., Chi, M. N., Tseng, H-Y., Farrelly, M., Atmadibrata, B.

MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer

- Guo, S. T., Jiang, C. C., Thorne, R. F., Jin, L., Zhang, X. D., Wang, G. P., Li, Y. P., Wang, C. Y., Guo, X. Y., Yang, R. H., Feng, Y., Wang, F. H., Tseng, H-Y.

Suppression of PP2A is critical for protection of melanoma cells upon endoplasmic reticulum stress

- Tay, K. H., Jin, L., Zhang, X. D., Tseng, H. - Y., Jiang, C. C., Ye, Y., Thorne, R. F., Liu, T., Guo, S. T., Verrills, N. M., Hersey, P.

Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress

- Dong, L., Jiang, C. C., Thorne, R. F., Croft, A., Yang, F., Liu, H., de Brock, C. E., Hersey, P., Zhang, X. D.

Phosphatidylinositol 4,5-Bisphosphate 5-Phosphatase A regulates PI3K/Akt signaling in human melanoma cells

- Ye, Y., Jin, L., Zhang, L. J., Scolyer, R., Hersey, P., Zhang, X. D., Wilmott, J., Hu, W. L., Thorne, R. F., Dong, L., de Bock, C., Jiang, C. C., Rizos, H., Wu, M.

Targeting anti-apoptotic mechanisms for reversal of resistance to BRAF inhibitors in melanoma

- Hersey, P., Wroblewski, D., Lai, F., Jiang, C. C., Zhang, X. D.

Apoptosis of human melanoma cells induced by inhibition of B-RAFᵛ⁶⁰⁰ᴱ involves preferential splicing of bimS

- Jiang, C. C., Lai, F., Zhang, X. D., Tay, K. H., Croft, A., Rizos, H., Becker, T. M., Yang, F., Liu, H., Thorne, R. F., Hersey, P.

Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIPL from degradation by the E3 ligase itch in human melanoma cells

- Yang, F., Tay, K. H., Zhang, X. D., Dong, L., Thorne, R. F., Jiang, C. C., Yang, E., Tseng, H-Y., Liu, H., Christopherson, R., Hersey, P.